{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T06:18:39Z","timestamp":1773037119456,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ygyno.2013.10.012","type":"journal-article","created":{"date-parts":[[2013,10,18]],"date-time":"2013-10-18T08:45:59Z","timestamp":1382085959000},"page":"734-743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["The synthetic flavonoid WYC02-9 inhibits cervical cancer cell migration\/invasion and angiogenesis via MAPK14 signaling"],"prefix":"10.1016","volume":"131","author":[{"given":"Yun-Ju","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Jen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amos C.","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang-Chang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Feng","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chang","family":"Tyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyng-Shiou F.","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2013.10.012_bb0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bpobgyn.2011.11.004","article-title":"Alternative approaches to cervical cancer screening for developing countries","volume":"26","author":"Wright","year":"2012","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0010","series-title":"Cancer: principles and practice of oncology","year":"2007"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0015","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.ygyno.2008.05.012","article-title":"The current role of neoadjuvant chemotherapy in the management of cervical carcinoma","volume":"110","author":"Gonz\u00e1lez-Mart\u00edn","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0020","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0025","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1016\/j.ygyno.2007.07.004","article-title":"Chemotherapy for recurrent cervical cancer","volume":"107","author":"Cadron","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0030","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: mode of cytotoxic action and molecular basis of resistance","volume":"22","author":"Siddik","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0035","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/carcin\/21.3.525","article-title":"Chemoprevention of cancer","volume":"21","author":"Sporn","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0040","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nrclinonc.2012.120","article-title":"Cancer prevention by targeting angiogenesis","volume":"9","author":"Albini","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0045","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-3-540-78281-0_5","article-title":"Angiogenesis inhibition in cancer therapy: platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) and their receptors: biological functions and role in malignancy","volume":"180","author":"Appelmann","year":"2010","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0050","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/ijc.21128","article-title":"MMP and TIMP assay in cancer. Biological and clinical significance","volume":"116","author":"Giannelli","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0055","first-page":"605","article-title":"In vitro modulation of MMP-2 and MMP-9 in human cervical and ovarian cancer cell lines by cytokines, inducers and inhibitors","volume":"23","author":"Roomi","year":"2010","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0060","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1007\/s000180050369","article-title":"The stress-activated protein kinase pathways","volume":"55","author":"Tibbles","year":"1999","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0065","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1016\/S0024-3205(01)01411-4","article-title":"MAPK (ERK2) kinase\u2014a key target for NSAIDs-induced inhibition of gastric cancer cell proliferation and growth","volume":"69","author":"Husain","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0070","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1038\/sj.cdd.4402187","article-title":"p38 MAPK and MSK1 mediate caspase-8 activation in manganese-induced mitochondria-dependent cell death","volume":"14","author":"El Mchichi","year":"2007","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1476-4598-12-35","article-title":"Role of p38 and JNK MAPK signaling pathways and tumor suppressor p53 on induction of apoptosis in response to Ad-eIF5A1 in A549 lung cancer cells","volume":"12","author":"Taylor","year":"2013","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0080","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1023\/A:1012437607881","article-title":"Mechanisms of tamoxifen-induced apoptosis","volume":"6","author":"Mandlekar","year":"2001","journal-title":"Apoptosis"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0085","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.molmed.2004.01.007","article-title":"p38 MAP kinase: a convergence point in cancer therapy","volume":"10","author":"Olson","year":"2004","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0090","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10555-012-9347-y","article-title":"Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities","volume":"31","author":"Weng","year":"2012","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0095","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cbi.2006.08.003","article-title":"Black rice anthocyanins inhibit cancer cells invasion via repressions of MMPs and u-PA expression","volume":"163","author":"Chen","year":"2006","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0100","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ijc.20620","article-title":"Flavonoid apigenin inhibits motility and invasiveness of carcinoma cells in vitro","volume":"114","author":"Czyz","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0105","first-page":"619","article-title":"Effects of quercetin and quercetin in combination with cisplatin on adhesion, migration and invasion of HeLa cells","volume":"43","author":"Zhang","year":"2008","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/bcpt.12057","article-title":"Total synthetic protoapigenone WYC02 inhibits cervical cancer cell proliferation and tumour growth through PIK3 signalling pathway","volume":"113","author":"Chen","year":"2013","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0115","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.freeradbiomed.2011.01.015","article-title":"A novel synthetic protoapigenone analogue, WYC02-9, induces DNA damage and apoptosis in DU145 prostate cancer cells through generation of reactive oxygen species","volume":"50","author":"Chen","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0120","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.lfs.2013.04.007","article-title":"The synthetic flavonoid WYC02-9 inhibits colorectal cancer cell growth through ROS-mediated activation of MAPK14 pathway","volume":"92","author":"Chen","year":"2013","journal-title":"Life Sci"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0125","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1055\/s-2005-871292","article-title":"New cytotoxic flavonoids from Thelypteris torresiana","volume":"71","author":"Lin","year":"2005","journal-title":"Planta Med"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0130","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1021\/jm070363a","article-title":"First total synthesis of protoapigenone and its analogues as potent cytotoxic agents","volume":"50","author":"Lin","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0135","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/jnci\/djs355","article-title":"Role of MRE11 in cell proliferation, tumor invasion, and DNA repair in breast cancer","volume":"104","author":"Yuan","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0140","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1124\/jpet.107.135442","article-title":"Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1\/2","volume":"325","author":"Chang","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0145","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1095\/biolreprod.103.023531","article-title":"The modulatory role of transforming growth factor beta1 and androstenedione on follicle-stimulating hormone-induced gelatinase secretion and steroidogenesis in rat granulosa cells","volume":"70","author":"Ke","year":"2004","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0150","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1002\/ijc.21771","article-title":"STAT3 ser727 phosphorylation and its association with negative estrogen receptor status in breast infiltrating ductal carcinoma","volume":"118","author":"Yeh","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0155","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00666038","article-title":"Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors","volume":"36","author":"Weidner","year":"1995","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0160","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/ptr.2677","article-title":"Ginger's (Zingiber officinale Roscoe) inhibition of rat colonic adenocarcinoma cells proliferation and angiogenesis in vitro","volume":"23","author":"Brown","year":"2009","journal-title":"Phytother Res"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0165","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.4049\/jimmunol.167.3.1644","article-title":"Evidence of IL-18 as a novel angiogenic mediator","volume":"167","author":"Park","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0170","series-title":"The zebrafish book: a guide for the laboratory use of zebrafish","author":"Westerfield","year":"1993"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0175","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1023\/A:1026598300052","article-title":"Zebrafish angiogenesis: a new model for drug screening","volume":"3","author":"Serbedzija","year":"1999","journal-title":"Angiogenesis"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0180","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1096\/fj.02-0329fje","article-title":"p38 MAP kinase\u2014a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability","volume":"17","author":"Issbr\u00fccker","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0185","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00109-011-0723-9","article-title":"Ginsenoside-Rg1 enhances angiogenesis and ameliorates ventricular remodeling in a rat model of myocardial infarction","volume":"89","author":"Yin","year":"2011","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0190","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1158\/1541-7786.MCR-09-0068","article-title":"Requirement of phosphatidylinositol(3,4,5)trisphosphate in phosphatidylinositol 3-kinase-induced oncogenic transformation","volume":"7","author":"Denley","year":"2009","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0195","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1158\/1078-0432.CCR-11-2485","article-title":"Pathway-specific analysis of gene expression data identifies the PI3K\/Akt pathway as a novel therapeutic target in cervical cancer","volume":"18","author":"Schwarz","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0200","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.canlet.2008.05.048","article-title":"(\u2212)-Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells","volume":"271","author":"Lim","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0205","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1038\/sj.onc.1210840","article-title":"Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAILmediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis","volume":"27","author":"Siddiqui","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0210","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/pros.10352","article-title":"Treatment of epigallocatechin-3-gallate inhibits matrix metalloproteinases-2 and \u22129 via inhibition of activation of mitogen-activated protein kinases, c-Jun and NF-kappaB in human prostate carcinoma DU-145 cells","volume":"59","author":"Vayalil","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0215","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/714007543","article-title":"Aminopeptidases and angiogenesis","volume":"10","author":"Sato","year":"2003","journal-title":"Endothelium"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0220","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.3390\/ijms12107077","article-title":"Biomarkers in tumor angiogenesis and anti-angiogenic therapy","volume":"12","author":"Pircher","year":"2011","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0225","first-page":"3374","article-title":"Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation","volume":"59","author":"Gorski","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2013.10.012_bb0230","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1200\/JCO.2002.01.033","article-title":"Mechanisms and future directions for angiogenesis based cancer therapies","volume":"18","author":"Scappaticci","year":"2002","journal-title":"J Clin Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813012614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813012614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T23:54:12Z","timestamp":1564530852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825813012614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0090825813012614"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.10.012","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The synthetic flavonoid WYC02-9 inhibits cervical cancer cell migration\/invasion and angiogenesis via MAPK14 signaling","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}